Regentis Biomaterials Ltd. (NYSE American: RGNT) is advancing GelrinC(R), a cell-free hydrogel implant designed to repair ...

Osteoarthritis (OA) is a debilitating joint disease which affects over 500 million people worldwide, with trends increasing as populations age. OA is caused by progressive, irreversible degeneration ...

Regentis Biomaterials Ltd. (NYSE American: RGNT) is advancing GelrinC(R), a cell-free hydrogel implant designed to simplify ...

A viral claim states that Germany developed an injectable gel that repairs damaged cartilage naturally. Read on to know more about the claim.

Add Yahoo as a preferred source to see more of our stories on Google. A newly developed biomaterial might be able to treat crippling arthritis by prompting the growth of new cartilage, a new study ...

Northwestern University scientists have developed a cell-free bioactive material comprising a complex network of molecular components that work together as a scaffold to mimic cartilage’s natural ...

Even though the recently launched EU project ENCANTO (“magic” in Spanish) has nothing to do with the Disney movie of the same name, the study topic might sound like magic to the layman. "We take a ...

HERZLIYA, IL / ACCESS Newswire / January 20, 2026 / Regentis Biomaterials Ltd., (“Regentis” or the “Company”) (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair ...

Cartilage regeneration presents a formidable challenge owing to the tissue’s avascular nature and limited intrinsic repair capacity. Chondrogenesis, the process by which progenitor cells differentiate ...

Austin, Texas, June 1st, 2026, FinanceWireRegentis Biomaterials Ltd. (NYSE American: RGNT) is advancing GelrinC®, a ...